Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results

Click here to go back to your search results.

Brain Cancer treatment details. Chemotherapy. Immunotherapy. Radiation. Surgery. Nihon University School of Medicine, Tokyo, Japan

Survival: 13.0 months
Toxicity Grade: 3
Treatments: Chemotherapy
Country: Japan
City/State/Province: Tokyo
Hospital: Nihon University School of Medicine
Journal: Link
Date: 3/2005

Patients: This trial involved 58 patients: 22 had anaplastic astrocytoma, and 36 had glioblastoma multiforme. Thirty-four patients were men, and twenty-four were women. Overall, the median age was 53 years.

Treatment: The treatment consisted of surgery, radiation therapy, the immunotherapeutic agent human interferon beta (IFN-b), and the chemotherapeutic agent nimustine hydrochloride.

Toxicity: No grade 4 toxicities were reported. Grade 3 toxicities included neutropenia.

Results: The median overall survival was 16 months. For anaplastic astrocytoma patients, the median survival was 58 months. For glioblastoma multiforme patients, the median survival was 13 months. The authors concluded that post-surgery interferon-nimustine-radiation treatment may have therapeutic benefit for anaplastic astrocytoma patients.

Correspondence: Takao Watanabe, MD

E-mail to a Friend Email Physician More Information